Brief: Aroa Biosurgery Says Preliminary Unaudited FY23 Normalised EBITDA Positive

Aroa Biosurgery

27/04/2023 02:30

April 27 (Reuters) - Aroa Biosurgery  ARX.AX :
    * PRELIMINARY UNAUDITED FY23 FULL YEAR NORMALISED EBITDA
POSITIVE
    * PRELIM UNAUDITED FY23 TOTAL REVENUE ABOUT NZ$63.4 MILLION,
GROWTH OF 60%

Source text for Eikon:  ID:nASX29W3nZ 
Further company coverage:  ARX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))